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1. Introduction
The therapeutic promise of transplanting organs from cadaveric donors, as envisioned by the
pioneers of transplantation, has never been kept because the demand for cadaveric organs has
by far exceeded the supply.
Besides the fact that renal transplantation is the optimal treatment for patients with end stage
renal disease, it provides benefits to the society as a whole as well as to the recipients. Yet, the
donor shortage poses a significant challenge to the transplant community and bare unfavor‐
able consequences: prolonged waiting time and compromise patient survival. Sustained efforts
were done during times to increase both the deceased donor and living donor pool.
The expanded criteria donors also known as non-traditional donors has been credited to lessen
the current shortage of grafts available for transplantation by providing more grafts. Any such
attempt is a two-edged sword since it increases the outcome risk of the suboptimal grafts.
Criteria for living donation were more restrictive compared with cadaver donation but such
reluctance to use living donor marginal grafts is declining since transplantation is a better
option than dialysis.
Expansion criteria allows transplantation of grafts from deceased donors at the extreme age
(above 60 and below 16), with history of hypertension, diabetes or malignancy, hemodynam‐
ically unstable, non-heartbeating, seropositive for hepatitis B or C, with systemic infections, at
high-risk for HIV infection, reduced renal function, anatomic anomalies, or injuries [1].
The waiting list for transplant organs continues to grow and many patients continues to die
while waiting or become unsuitable for organ transplantation. Consequently, many patients
with end stage organ failure are no longer relaying on the waiting list for cadaver transplan‐
tation. There is a trend not only to reconsider the living donor but also to turn the attention
toward spouses, friends or even strangers as possible donors. From medical point of view, all
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these are acceptable alternatives due to advances in immunosuppression which have elimi‐
nated the requirement for a perfect genetic match for a successful organ transplantation. In
many US transplant centers, the number of kidneys obtained from living donors has exceeded
the number of kidneys obtained from cadaver [2].
Although organs from living donors can be transplanted safely, concerns about the protection
of well-being of such donors has prompted the transplantation community to develop a
consensus statement, emphasizing that a living donor should be competent, willing to donate
an organ, and free of coercion.
Regardless of donor type and graft quality, one should keep in mind that never should be
transplanted grafts with a heightened potential for the development of a progressive disease.
Since the rules are continuously evolving, the approach to use of each graft and recipient
selection should be done with caution in order to obtain acceptable results.
2. The living donor
The use of living donors for renal transplantation was critical for the early development of the
field, and in fact, preceded the use of cadaveric donors. At the moment, 20-22% of all kidney
transplants performed in the world were done with grafts from living donors. Most donors
are related genetically to the recipient, but there is an increasing percentage of cases, where
donors are genetically unrelated and includes spouses, friends, or other emotionally related
individuals. As it is known, ethical guidelines mandate that the living donors should not be
coerced and there will be no evidence of financial profit for the donor. As a consequence, the
donation should be considered "a gift of extraordinary value". It is known that the use of living
donors has been associated with a higher success rate than that seen with cadaveric donation.
Due to a higher demand for transplantation and the lack of a parallel increase in the number
of available cadaveric organs, living donation is the only solution for some patients to avoid
long times on waiting list, and occasionally, even the need of dialysis (1).
Better results (both long and short-term)
Consistent early function and easier management
Avoidance of long waiting time for transplantation
Less aggressive immunosuppressive regimens
Emotional gain to donor
Table 1. Advantages of living donation
There is a remote risk of catastrophic outcome of the living donor (1 in 3200 patients), but most
transplant centers and surgeons accept this. Some centers accept only living related donors; others
accept related as well as unrelated donors. These centers come to turns with the possibility of
harming living donors by being highly selective in their acceptance of donors. While surgically
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pragmatic, there is a philosophic fallacy in this approach. The important issues regarding the
donor, in addition to medical suitability, are whether the donor understands the risk of nephrec‐
tomy and whether the donor freely consents. The risk for the donor is the same regardless of the
donor's relationship to the recipient and regardless of the recipient's outcome. The risk for the
surgeon, that is the death of the donor, is no less devastating for the surgeon if the patient is a close
relative to the recipient than if the donor is a stranger.
2.1. Evaluation of the living donor
Usually, the potential living donor is the one who initiates the discussion about donation,
although the recipient or the physician can also rise the issue. The donor than meets with the
nephrologist, transplant surgeon, social worker, and transplant coordinator. All donors are
informed of the risks and benefits of the transplantation compared with the dialysis and the
risks to themselves by donating a kidney, on both short and long term [3, 4]. 1995 data of US
practices founded that reported mortality rate for living donors to be 0.03% and the morbidity
rate to be 0.23%. It is important to screen any relative of a patient with familial renal disease
(polycystic kidney disease, hereditary nephritis) for evidence of occult signs and symptoms,
in order to exclude such donors [5]. On the other hand, kidneys with minor renal abnormalities
can be used safely, once it is determined that function of the such kidneys could not be impaired
after transplantation [6].
Initial evaluation of all potential donors consists of blood and tissue typing. Usually, those
with ABO incompatibility are excluded; compatibility with the Rh factor is unnecessary. All
blood group compatible donors are then tested with the T lymphocyte cross-match. A negative
cross-match will allow further consideration for donation. In the case of multiple potential
donors, the better the antigen match, the grater is the likelihood of being selected for donation,
if all other testing are within normal limits. In general, as long as the donor and the recipient
have a negative T cell cross-match, the operation can be cared out. This is true for both related
and non-related donors who are ABO compatible. Many centers perform a mixed lymphocyte
reaction (MLR) as part of the routine evaluation, but the importance of this test has decreased
with the introduction of better immunosuppression.
Further evaluation for a potential donor consist of a complete medical history and a complete
physical examination, routine laboratory, testing, and serologic evaluation for EBV, herpes
virus, CMV, HIV, and hepatitis B and C viruses. Urinalysis and culture along with 24 hour
urine collection for creatinine clearance and protein excretion, are included as part of the
routine evaluation. If there is any concern regarding a borderline hypertensive pressure
reading, the blood pressure should be measured on the least three and as many as ten separate
occasions. Once all laboratory testing has been performed, the next step is renal arteriography
with an excretion faze to visualize the collecting system. This eliminate the need for intrave‐
nous pyelography. Such testing can be performed on an outpatient basis. Nowadays spiral CT
scan has been used routinely instead of conventional angiography in all centers. The use of
magnetic resonance (MR) angiography is also growing in importance. Donors are judged
unsuitably for a variety of reasons (2).
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Absolute
Lack of discernment
Alcohol or drug addiction
Age less than 18 years
Hypertension: blood pressure over 140/90 mm Hg requiring medication
Diabetes: abnormal glucose tolerance test or HbA1c
Proteinuria: over 300 mg/24 hours
Abnormal glomerular filtration rate: creatinine clearance less than 75 mL/min.
Microscopic hematuria of unexplained cause
History of thrombosis or thrombembolism
Medical significant illness: chronic lung disease, recent malignant tumor, heart disease,
vascular collagen disease,
History of bilateral kidney stones
Family history of autosomal dominant polycystic kidney disease (ADPKD), unless
ultrasound or CT scan is normal and age is over 30 years
Familial history of renal cancer
Bilateral fibromuscular arterial dysplasia
Long-term use of nephrotoxic drugs
HIV positive
Hepatitis B antigen-positive to a negative recipient or unprotected
Other severe infections
Relative
Anatomic abnormalities of the donor's kidney: vascular or urological
Obesity: 30% or more above ideal weight
Young donor with a first degree relative with type I diabetes or renal disease
Significant previous abdominal surgery
Single history of unilateral renal stone disease
ABO incompatible
Positive cross-match
Smoking
Psychiatric disorders
Table 2. Exclusion criteria for living donors
Anyone at risk for the development of acquired renal disease should be excluded.This includes
individuals with diastolic blood pressure constantly above 90 mm Hg, or who required
hypertensive medication to control their blood pressure.
History of hypertension is not by itself a reason for exclusion if the donor is normotensive and
off medication, but the donor should be carefully examined for preexisting renal disease or for
the risk of development of renal disease later in life.
Potential donors for siblings with diabetes routinely undergo a five hours glucose tolerance
test, and 24 hour urine specimen must be free of proteinuria. Some centers require that the
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donor be at least 10 years older than the age of the recipient at the time of diagnosis of the
diabetes. The measurement of the haemoglobin A1c and anti-islet antibodies also can be
included in the evaluation of any potential related living donor for a recipient with diabetes.
Unexplained microscopic hematuria may be an indication of an underlying renal disease such
as glomerulonephritis, but it may not be detected before donation. Finding as few as three red
cells per high power field may appear unimportant at first but may be an indicator of potential
future problems.
History of thrombembolism or thromboflebitis places the potential donor at increased risk of
pulmonary embolism and therefore it precludes donation. This is also true for patients with
heart disease, or history of malignant neoplasia. Obesity may be a relative contraindication for
any potential donor, if it is more than 30% above ideal body weight. These individuals should
be advised to loose the excess body weight before the transplant is scheduled, to decrease the
risk of pulmonary embolism or cardiac complications.
Patients with clinically significant psychiatric disorders should be fully evaluated by a
psychiatrist to established that the donor understands and agrees to the proposed procedure.
Once a full evaluation has been performed, if examination of the donor's kidney vascular
supply and drainage system reveals an abnormality, it must be decided whether the risk
imposed on the donor or the recipient are too great. With regard to vascular abnormalities we
tend to use donor kidneys with three or more arteries if there is a good immunological
correspondence and a strong determination for donation and if dialysis tolerance of the
recipient is bad [7,8]. Abnormalities such as aneurisms, renal artery stenosis, fibro-muscular
dysplasia, if limited in sized and area, can often be resected, repaired, or excised on the back
table. Such pathological addition should bee limited to one kidney, living as a rule, the normal
kidney in place. Given this caveats, it may be possible to use such donors [9].
Excision and reconstruction of such abnormalities is, in a sense, a of form of treatment of this
donors, although care must be taken to avoid living either the donor or the recipient with less
than a perfect outcome.
2.2. Preoperative management
Once the evaluation has demonstrated that there are no abnormalities serious enough to
exclude donation, the donor can be admitted to the hospital after a spiral CT scan was
performed. Many insurance companies are now restricting admissions to the day of the
operation. In such cases intravenous hydration can be given overnight on an outpatient basis,
or started on arrival at the hospital. Such hydration is important to help ensure adequate
diuresis during the donor operation. Preoperative assessment by the anesthesiologist and the
pain management team can make for a more comfortable postoperative recovery.
The donor is instructed preoperatively on the use of spirometer, and on the use of leg support
stockings and the sequential compression device system to prevent venous stasis. After
entering the operating room and before the incision, the patient should receive a dose of
intravenous antibiotic. Although preoperative skin cleaning is recommended; hair clipping is
avoid until just before incision.
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2.3. Surgical alternatives in life donor nephrectomy
Regarding the surgical habits and the existing experience, there are several ways of harvesting
kidneys from living donors [10-12].
• Classic transperitoneal approach, either throw midline, or throw a left or right subcostal
incision.
• Subcostal extraperitoneal approach (left or wright).
• Dorsal lumbotomy approach. The incision can be performed either underneath the XIIth
rib, resecting the XIIth rib, or above the XIIth rib (extraperitoneal, extrapleural).
• Laparoscopic approach either transperitoneal or retroperitoneoscopic.
2.4. Laparoscopic approach for living donor nephrectomy
The introduction of laparoscopic living kidney donation has been a major advance in organ
donation. First introduced with some reticence only in selected centers, this procedures are
now the preferred surgical approach in almost all transplant programs in United States and
Europe. Usually, the program that offers this kind of procedure have a high rates of living
kidney donation. The major benefit of laparoscopic technique includes significant reduction
of surgical pain, postoperative convalescence, and recovery time. As a result, the laparoscopic
donor nephrectomy has been responsible for expanding the pool of living donors and may
account for the increased popularity and frequency of living donation. Long term renal
function is not different between open nephrectomy and laparoscopic nephrectomy. About
75% of living donor transplant nephrectomies world wide employ laparoscopic technique,
either transperitoneal or retroperitoneal.
2.5. Open living donor nephrectomy
The traditional method for removing kidney from a living donor has been open surgical
technique, in majority of cases using a flank incision. In selected cases in which the donor has
motivation which precluded laparoscopic access (e.g. significant prior abdominal surgery), or
in some cases of complex vascular anatomy, an open surgical approach is preferred. Some
centers advocate the use of open surgery for pediatric patients, although the age of recipient
is not universally considered an indication for open renal procurement. Most donor surgeon
use a donor flank incision, extra pleural and extra peritoneal above or below the XIIth rib.
As it is in any surgical approach, the kidney must be very carefully dissected to preserve renal
veins and periureteral blood supply. Excessive pressure on the renal artery is avoided to
prevent a vasospasm. After the renal vessels are securely ligated and divided the kidney is
removed and placed in a basin of frozen saline slush to decrease the renal metabolism and
after that the vessels are un-ligated and flushed with heparinized solution for both procedures,
either laparoscopic harvesting or classic surgery.
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2.6. Postoperative care
Postoperative care of a living donor is fairly standard. Adequate postoperative analgesia is a
key factor including postoperative complications such atelectasia and pneumonia [15].
Infections should not occur with appropriate antibiotic prophylaxis. The continuous use of leg
stoching and sequential compression devices are essential to prevent deep venous thrombosis
of the lower limb. Most patients are often ambulatory by postoperative day 1 or 2 and tolerating
oral feedings by postoperative day 2 or 3. The donor can be discharged by postoperative day
2 to 6. The renal function of the donor should be assessed periodically after the operation, as
some patients experience a 25% increase in serum creatinine level; this should return near
baseline by 3 months after the operation. In fact there are no convincing data to suggest that
living donors are at any increased long term risk as a result as having donating the kidney.
2.7. Long term complications
The immediate operative risk to the donor can be stated with some certainty but the long terms
effects are not completely understood. Follow-up, in general, is reassuringly but incomplete.
Most folow-up studies of living kidney donors find no decrease in long term survival. All
existing follow-up found an at least 85% survival up to 31 year after donation, compared to a
predicted 66% in general population of similar age. The survival advantage at the living donors
was attributed to the selection bias of only healthy individual as renal donors and at better
follow up for them. Concerns regarding the possibility that donors will develop end stage renal
disease (ESRD) is:
• hyper filtration in the remaining kidney will lead to focal segmental glomerulosclerosis and
renal failure, that is donation per se will cause renal failure,
• the second concern is that donor will develop primary renal disease. The donors who
develop primary renal disease will progress to renal failure more quickly because they have
a lower than normal renal mass at onset of a primary renal disease. The later concern applies
to a family with a history that put them for a risk of renal disease, for example: patient with
type II diabetes.
Many follow-up studies have noted an increase in hypertension and proteinuria as well as a
statistically but not clinically significant increase in serum creatinine. There are studies which
found an increase in 20% of patients with blood pressure (15%-48%) [16] but it is not clear if
hypertension is more common to this group than in general population.
Another study is finding that 35% of patients are taking anti-hypertensive medications and
23% are having proteinuria compared with 44% and 22% respectively for controls [17]. On the
other side, even if the donor has a normal renal function, the glomerular filtration rate is in
fact maintained by hyper filtration.
One thing is for sure, that in all follow-up studies, majority of the donors which are altruistic
donors, drive a tremendous degree of satisfaction and an increased of self esteem for their
donation. As a consequence, donors interviewed considered their donation as an act of heroism
and generosity with which nothing else in their life can be compared [18]. More than 90% said
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that they would donate if they have it to do over again, and fewer than 10% expressed any
regret about donating [19].
2.8. Policies to enhance living donation
The therapeutic  promise  of  transplanting organs  from cadaveric  donors  has  never  been
kept  because  the  demand for  transplantation  has  by  far  exceeded the  possibilities.  The
waiting  list  for  transplants  continues  to  grow  and  in  2005  nearly  5000  patients  were
removed from the waiting list because of the death. Consequently many patients with end
stage organ failure are no longer relaying on waiting list. Than the attention was turning
toward living donors others than they have been classically admitted i.e. toward spouses,
friends,  or  even  strangers,  as  possible  donors.  From  medical  point  of  view,  these  are
acceptable  alternatives,  due  to  the  fact  that  immunosuppression  has  eliminated  the
requirement for a perfect genetic match in order to have a successful transplantation [20].
In  many  centers  world  wide,  specially  US  transplantation  centers  and  scandinavian
transplant centers,  the number of kidneys transplanted from living donors has exceeded
the number of kidneys obtained from cadaver donors (over 35%) [21].
Although donors from living donors can be transplanted safely, concerns about the protection
of well being of donors has prompted the transplantation community to develop a consensus
statement emphasizing that a living donor should be competent, willing to donate an organ,
and free of any kind of coercion [22]. More than that, the new reliance on organs from living
donor has increased the risk of donation for financial reasons, especially in the case of unrelated
donor. It is world-wide admitted that organ donation has to rely on the voluntarism and
altruism, and uncompensated family members of the donor.
Donor type 1990 2000 2010 relative ratio
Cadaveric 4306 5489 7241 + 1,68
Biologically related
living donors 1831 4030 3046 + 1,66
Emotionally related
living donors 59 667 715 + 12,11
Unrelated living donors 204 804 2516 + 12,33
Total transplants 6400 10990 13518 + 2,11
Table 3. Reported kidney transplants performed in USA [OPTN data]
The purchase of organs is explicitly unlawful in Europe, US, as virtually all other countries but
the shortage of cadaveric organs has led to a world-wide black market for organs from living
donors. That's why patients with sufficient means can travel to distant locations in order to
purchase kidneys for transplantation [23, 24].
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This is a dramatic situation which is generated by continuous shortage of organs for trans‐
plantation and by the increasingly donation rate from unrelated living donors. Such a situation
require significant changes in the transplantation laws which should permit the increase of
living donors and in the same time to stop the organ trade. Very difficult task.
The rate of living donation can be increased by two methods:
• organizing and ethic alternatives,
• medical methods are represented by: laparoscopic harvesting, paired kidney exchange,
transplantation of grafts with anatomic abnormalities (vascular, urinary tract or fusion),
acceptance of patients with low compatibility after a treatment with plasmapheresis and iv
Ig.
2.8.1. Organizing and ethic alternatives to increase the rate of living donation
The motives of living donors and the motives of families of deceased donors, are complex and
not necessarily always pure altruistic [25]. Spouses and siblings, who act as a living donor,
experience a personal reward seeing that the recipient well being is restored. Because the organ
donation is a voluntary and valuable act it should be considered as a charitable gift. Society
could explicitly thank the organ donors for their gift, as it is done with other charitable
contributions, without jeopardizing its altruistic basis. New legislations should embrace
ethically acceptable ways to encourage such charitable donation of organs.
2.8.1.1. Incentives for organ donation
The issue of public incentives to enhance donation is more than just complex but mainly
sensitive. From a philosophical point of view, the body is a part of our personality, thus in
respect with human dignity it would be wrong to use parts of our body as means only [26].
On the other hand, one may assert that everyone is the rightful owner of his person supporting
the idea that the self can decide over its body like any kind of property [27].
Most frequently, the background attitude of general population is to reject incentives for
donation but there might be circumstances under which attitudes may change [28]. For
instance, when the process became transparent: the amount of compensations are specified or
there might be some ethical reasons to do so. The main risk is exploitation of those severe
impoverished on a black market [29].
The valuable exchange of organs is prohibited worldwide, yet there exists national law or
regulations which allows incentives for deceased or living donation [30]. Such incentives
including financial reimbursement, health care-related reimbursement or other recognition for
living donors or deceased donors’ families have been widely debated [31].
Donor medal of honor. Organ procurement organizations must have ceremonies which
recognize and appreciate organ donation. A donor medal of honor enacted by a top official of
the country expresses the appreciation and gratitude on behalf of the whole community to the
living donors and even to the families of the deceased donor [32, 33].
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Medical leave for organ donation. Currently organ donors risk loss of wages or even loss of
employment because the time away from the work that is required for donation [34,35]. In
many countries there are legislations that provide a 30 day medical leave for all employees
who donate an organ for transplantation [36]. However, no one should have to incur a personal
expense for donating an organ. Many national organizations are doing an effort to encourage
hospitals with transplantation services to provide paid medical leave for employees who
become organ donors. Even if legislation emphasizing that enrichment should not be the
reason for the donation, paid medical leave has to be available to a larger number of would-
be donors [37].
Ensuring access to organs for previous donors. As you have seen up to now, the majority of
living donors are doing well after donation. However, it has been established that at 10 years
after donation, under 5% of those who donated the kidney developed ESRD; this donors are
being placed on waiting list for cadaver organs [38]. Despite the additional allocation priority
points, these donors have to wait for a cadaveric kidney, some of them for a long period of
time. The health and well being of living donor should be monitored in a follow-up register
in order to document medical problems associated with donation that occur over ensuing years
[22]. The need for a transplant in a previous kidney donor should be considered a high priority
in the allocation of the organs.
Donor insurance. The fact that there are being cases in which a kidney donor died immediately
after donation or needed a kidney transplant at a later date, serves as a reminder that a
nephrectomy (any kind of nephrectomy) is not a risk free procedure. A survey at some centers
of transplantation show that at least two kidney donors had died from perioperative compli‐
cations after a kidney donation and some of them had a persistent complication [39].
As a consequence, it should be enacted national plans to provide life and disability ensures for
all living donors including a mechanism to ensure that they do not incur catastrophic medical
expenses as a result of a donation.
2.8.1.2. Organ exchanges
Since the report of Rapaport which introduced the concept of paired kidney exchange as a
method to enhance the number of living donors, these techniques have been applied in several
countries with lower cadaver donation rates like Mexico, South Korea, Japan, and Europe
(Holland and Romania).
Many persons who wished to donate an organ to a spouse or another family member where
unable to help them due to incompatible blood type or other immunological barriers (positive
cross-match). A program of paired kidney exchange addresses this problem by permitting an
exchange of organs from two living donors [34] or from one living donor to one deceased
donor. In the later approach, recently introduced in New England and Holland, a living donor
incompatible with his intending recipient, donates an organ to a compatible patient on the
waiting list for cadaveric organs in exchange for a priority allocation of a cadaveric organ to
the donor's intended recipient. Thus, two transplantations are performed in circumstances that
otherwise had permitted neither. Because such exchange could open the door to a paid
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donorship, the same prohibition against the payment donor should be applied to organ
exchanges.
Legal issues. Initially, most countries limited traditional transplantation to genetically of strong
emotionally related pairs. With extend of paired kidney donation, such limitations were
removed to allow both altruistic non-directed donation and paired donation. Although, any
exchange in paired donation represent in fact a transaction between parts, it do not involve
financial values. It is advisable that such a issue should be explicitly addressed by the legal
framework of every country.
Allocation algorithm. Grafts allocation in paired kidney donation is one of the domain who
largely benefits from theories derived from economics regarding stable allocation and the
practice of market design [40]. The main goal is to maximize the number of matched pairs.
Any such program should overcome the disadvantage of O recipients by increasing the
likelihood to receive a compatible graft. The risk of a positive cross-match with a from the
donor pool might be assessed by considering the HLA antibody profile of the recipients and
the HLA profile of the donors [41, 42]. When done on a national scale, such a matching should
include distance between transplant centers, matching the virusologic profile of the recipient
and donor, donor’s age and size. Recipients from such pairs will be suspended from the waiting
list until either they will be transplanted or a incompatibility test will reveal that the exchange
is not possible. List paired donation may increase the rate of transplants by expanding the
donor pool. In such an exchange, an incompatible donor who will donate to a recipient from
the waiting list while his recipient will receive a high priority for the allocation for a deceased
donor kidney [43, 44]. There are several concerns regarding ethical and legal issues. Such a
transplant is designed to give an alternative to O blood type recipients with a non-O incom‐
patible donor. The immediate consequence is the transplantation of a non-O blood group
recipient from the waiting list and the addition of a O blood group recipient. This way, there
will be an increased pressure over the O blood group recipients [43, 44].
Matching algorithms. Different matching algorithms were designed to maximize the number
of recipients with an incompatible living donor will undergo renal transplantation. After an
initial experience with two pairs, the number of pairs involved in a paired kidney transplan‐
tation increases to three, four and even more and the procedure gain worldwide acceptance.
Involving of more than two pairs increases the chances to get a renal transplant but in order
to avoid the withdrawal risk requires six or more operations to be done at the same time.
Designed for O blood group recipients, exchanging of an incompatible kidney for a preferential
position on the waiting list increases the recipient’s chances for a renal transplantation but
decreases the chances of other O blood group recipients from the waiting list [45-48]. This
situation creates ethic dilemmas. Generalizing such list exchanges to any blood group recipient
with a living donor available but incompatible, may overcome this issue.
Altruistic donation or non-directed donation is more ethical and legal challenging. It is difficult
to believe and understand that a good Samaritan really exists and even when exists, national
law framework should allow transplantation from unrelated living donor. Altruistic donors
may be allocated to a waiting list or to initiate an open chain of paired transplantations [46,49].
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Utilizing living donors may decrease the pressure for renal transplantation. Moreover,
implementing of different types of kidney exchange could give further solutions to increase
the transplantation rates. Combining different approaches to kidney exchange may create
complex and versatile solutions to the incompatibility issue, even finding a better match for
compatible pairs.
2.8.2. Medical methods to increase the number of living donation
2.8.2.1. Acceptance of grafts with anatomic anomalies
The number of donations can be increased by accepting donors with anatomic anomalies
(multiples arteries, multiple veins, moderate dysfunction of the UPJ, renal cyst, complete
duplicate ureteral system, solitary stone) which can be corrected in bench surgery.
Anatomical anomalies of the kidney have been considered for a long time as an absolute
contraindication for living donation. Even now, many nephrological centers are including in
their exclusion criteria for live related or unrelated donation items like urological abnormalities
in donors or history or presence of any kidney stones.
But in our days, the majority of transplant centers with experience in the field, due to the
shortage of the living donors pool, are considering the contraindication for using grafts with
anatomical anomalies just a relative contraindication. Occasionally, the donor has minor
unilateral abnormalities such as a renal cyst, ureteropelvic junction obstruction, solitary stones,
duplex ureteral system, etc. If the related donor with a good immunological correspondence
with the recipient has an abnormal kidney and is the only one available and the evolution of
the recipient on hemodialysis is unacceptable, it is advisable to transplant the abnormal kidney,
living the donor with the best one.
2.8.2.2. Acceptance of donors with multiple arteries and veins
The management of multiple renal arteries (MRA) are considered technically demanding in
renal transplantation programs with kidneys from related or unrelated living donors. Some
programs consider the use of multiple arteries and veins as a relative contraindication, because
of increased risk of vascular and urological complications.
In addition, the rapidly increasing laparoscopic kidney donation has been accompanied by a
significant shift in surgical practice [50,51]. Many centers which are performing laparoscopic
harvesting restrict it to the left kidney [52-54]. The limitation to the left kidney leads to a higher
utilization rate of kidneys with multiple arteries; in the literature, incidence of unilateral
multiple renal arteries is between 18% and 30%, unless one limits laparoscopic nephrectomy
only to the kidney with normal anatomy which is precluding 30% of all donors.
By accepting grafts with multiple renal arteries, one may theoretically accept an adverse effect
on the outcome of those grafts. Previous authors [55,56], stated that MRA in their reconstruc‐
tion were associated with several post-transplant complications. This is the motivation why
such anatomy was considered to be a transplant contraindication. The most frequent vascular
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complications which were encountered in reconstruction of multiple arteries were graft
thrombosis, stenosis of the renal artery, and an increased risk of reno-vascular hypertension
[55-57]. The most frequently ureteral complication encountered [58] were ureteral necrosis and
pelvi-caliceal fistulas.
Smaller arteries are more prone to develop premature atherosclerotic occlusion. If that happens
with a small accessory lower pole artery it would lead to ischemic distal ureteral stricture.
Any way, recent data collected from the centers and program of renal transplantation with
experience in the field, display above any doubt that procurement of kidneys with multiple
renal arteries can be accomplished safely and not impose additional medical, social, econom‐
ical or postoperative clinical evolution burden, on the donor and the recipient.
Overall intraoperative and early postoperative complications of the recipients are not signifi‐
cantly different from the evolution of the recipients who received grafts with single arteries.
A low rate of vascular complications is achieved using standard microvascular reconstruction
technique with or without autologous vein patches [59-61] or extension graft. More than that,
early graft function assessed by urine output and serum creatinine measurements were not
significantly different among grafts with single arteries or grafts with multiple reconstructed
arteries. In addition, long term quality of function, rejection, graft loss rates and graft survival
were also similar. More than that, overall graft survival rates of this patients is exceeding 90%
at 3 years.
In summary, the introduction of laparoscopic donor nephrectomy has significantly increased
the number of grafts with multiple renal artery. Utilization of this donors, increase the rate of
donation with 30% in specific centers. Modern techniques based on microsurgery have
reduced dramatically incidence of above mentioned complications. From a patient outcome
based perspective, this change in practice showed to be safe for both donors and recipients.
2.8.2.3. Laparoscopic donor nephrectomy - alternative to increase the rate of living donation
One great potential means for obtaining more kidneys is throw live donation. When compared
with cadaveric renal transplantation, living donor transplantation has several advantages, in
fact well known, which includes better graft survival, more rapid renal function after trans‐
plantation, shorter hospitalization and finally lower cost. However, several barriers exists for
potential living donors. Significant time is involved when one donates a kidney. Many
individuals do not have adequate financial and social support available that would allow them
to make a personal sacrifice and a time commitment necessary for kidney donation. Moreover,
the relatively prolonged convalescence can have significant financial impact on donor. Finally,
fear of pain as well cosmetic concerns, associated with flank incision, can militate against
kidney donation.
Laparoscopic living donor nephrectomy (LLDN) with all its alternatives (transperitoneal
approach, retroperitoneal approach, hand assisted laparoscopic nephrectomy) was introduced
in 1995 by Ratner and Kavoussi [62].
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Laparoscopic  nephrectomy is  more  technically  demanding than other  standard abdomi‐
nal  laparoscopic  procedures.  The surgeon experience  is  crucial  for  minimizing potential
morbidity.  Significant  operative  differences  are  between  open  and  laparoscopic  donor
nephrectomy.  The  later  approach  requires  a  different  set  of  technical  skills  than  that
associated with traditional open surgery. The endoscopic video image is only two dimen‐
sional and much narrower when compared with direct vision afforded by open surgery.
The types of instrumentation available for working throw the small  incision afford only
restricted degrees of freedom when compared to the human hand. Moreover,  the tactile
sensation,  currently  can  not  be  transmitted  through the  instrument.  The  differences  are
giving a  longer  operative time with one or  even two hours  when compared with open
donation. All these drawbacks are only partially eliminated by robotic surgery, even if now
there  is  a  three  dimensional  vision  of  operative  field  and  the  mobility  of  the  working
instruments is better than that of human hand.
Even so, laparosccopic renal donation and robotic laparoscopic harvesting offers both
introperatively and postoperatively great benefits to the donor.
Due to magnification provided by the optical system and the video camera, in experienced
hands, the dissection of the renal pedicle is more accurate and if it is realized through retro‐
peritoneal approach it is much more direct and quicker than classical approach.
The decreased size of the incision for extracting kidney and placement of that incision in the
lower abdomen, significantly reduce postoperative pain when compared with traditional
opened surgery; it also reduce traumatism of the abdominal wall, which is followed by a
quicker and better healing and mobilization postoperatively and quicker reintegration of the
patient in society.
Usually, these patients resume their oral intake in the first postoperative day and normal
alimentation in maximum two days after surgery.
All retrospective comparations between open and laparoscopic kidney donation show that
analgesic requirements for LLDN and robotic LDN, were 30% lower than those for open
procedures. Need for oral pain medication is also reduced.
Return to physical demanding work also occurs, on average, 17th days sooner for the laparo‐
scopic group compared with classic operation.
Recipient and graft survival. All retrospective review of the recipient who received a kidney
through laparoscopic or robotic laparoscopic donation compared with those who received
kidney via standard open nephrectomy shows no statistical differences if the groups are
matched in regard with the number of HLA mismatches, donor relationship, diabetes,
previous transplant, gender, or race.
Allograft function. The majority experience in the field attest that all grafts functioned intrao‐
peratively and no clinical significant injury occurred to the graft.
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Laparoscopic Open P value
Estimated blood loss
(mL) 266+/-174 393+/-335 0.027
Operative time (min.) 232+/-33 183+/-27 <0.001
Hospital stay (days) 3.0+/-0.9 5.7+/-1.7 <0.001
Analgesia (days of use)
Oral narcotics 4 12 <0.001
Acetaminophen 3 17 <0.001
Resumed oral intake
(days) 0.8+/-0.5 2.6+/-1.0 <0.001
Returned to work
(weeks) 4.0+/-2.3 6.4+/-3.1 0.003
Table 4. Open versus laparoscopic donor nephrectomy
Allograft rejection. The pneumoperitoneum and retropneumoperitoneum reduces renal blood
flow and urine output. The potential for ischemia can make the donor kidney more allogenic
by inducing MHC class II expression. This problem could be avoided giving donors intrao‐
peratively a 6-8 liters of crystalloid to promote brisk diuresis, and having an accurate dissection
of the renal pedicle and harvesting the kidney only in full diuresis. Biopsy proved rejection in
laparoscopically obtained kidney occurred in 30% of cases compared with 35.4% of cases of
kidneys harvested by open procedure. At 12 months, creatinine clearance in recipient of kidney
from laparoscopic and open procedure were both 66 mL/min. (p = not significant).
Laparoscopic nephrectomy gives less postoperative pain, quicker convalescence, better
cosmetic results when compared with traditional open operation. In experienced hands, this
procedure is accomplished without increasing the risks to donor safety and allograft function.
Complications are comparable to those reported in historic series using open surgery. Longer
operative time and the need of disposable equipment result in greater hospital costs. However,
quicker convalescence permit patients to resume activities sooner and produce market cost
savings both for patients and employer.
2.8.2.4. HLA sensitized and ABO incompatible donor and recipient
During the past decade, several innovative protocols have been adopted to overcome trans‐
plantation across a positive cross-match or an ABO blood group barrier. Protein A immu‐
noadsorbtion, high dose intravenous immunoglobuline (IVIG), low dose iv Ig in combination
with plasmapheresis, rituximab, splenectomy, all of them alone or in combination, can
abrogate a positive cross-match and enhance the chance of a highly sensitized patients to
receive a cross-match negative organ. Similar strategies can be used for ABO incompatible
donors and are particularly effective when the titter of blood group antigen is low.
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Plasmapheresis and intravenous immunoglobuline as a rescue therapy for a positive cross-match live
donor kidney transplants. The positive cross-match can present a virtually an insurmountable
barrier to kidney transplantation. Anti HLA antibodies have been identified as the predomi‐
nant cause of early graft failure from hyperacute rejection and acute humoral rejection.
Once the consequence of performing a transplant, in the face of a circulating donor specific
alloantibody were fully appreciated and routine pre-transplant cross-matching emerged as a
standard, hyperacute rejection became rare, but a large population of a highly sensitized
patients who have a little hope of receiving transplant has been subsequently identified.
Some of the longest waiting times for a kidney transplant are observed in patients who are
allo-sensitized because of a prior transplant, blood transfusions or pregnancy. Some of these
recipients have live donor, meet standards criteria for living donor transplantation, but have
a positive cross-match with their donor. A combination of plasmapheresis and IVIG under the
cover of standard doses of calcineurin inhibitors or rituximab, together with mycophenolate
mofetil and steroids, can effectively and durably remove donor specific anti-HLA antibody,
preemptively desensitize the recipient who had positive cross-matches with a potential live
donor, allowing the transplantation of this patients using a live donor without cases of
hyperacute rejection [63].
This preemptive therapy is initiated several weeks before a planned live donor transplant. Our
standard protocol was designed to include oral immunosuppressants before first plasmaphe‐
resis treatment followed by a maximum six plasmapheresis on alternate days. The recipients,
also received seven days of IVIG (100 mg/kg/day).
Cross-over transplantation and paired kidney exchange as a method to fill the gap of positive
cross-match and ABO incompatibility. The gap between the number of donors and number of
patients waiting for a kidney transplant continues to widen. Fewer patients get transplants
every year because of the organ shortage. This patients can receive a donor from a living donor
such a family member, a friend, or even a foreign individual.
The pool of such kidneys has not been fully utilized because not all living donors are compat‐
ible with their recipient. Patients with available living donor continue dialysis and many of
them die because of ABO incompatibility, cross-match positive, low HLA-matching. Since the
report made by Rapaport, when was set the bases of kidney exchange between two donor-
recipient pairs in order to obtain a better compatibility, things have changed [64-66]. A spouse
donor would give her kidney to an unrelated recipient who matched her blood type. That
recipient's mate would provide a kidney for the donor's ill spouse. This swap would imply
more than two pairs in order to obtain best compatibility. A cross-over renal transplantation
or a paired kidney exchange transplantation is defined by a living kidney donation or a living
kidney cadaver pool donation and exchange between two or more such couples who are
hindered by ABO incompatibility or positive cross-match to give the kidneys not to the own
recipients but solve the problem by cross-exchange the kidney between the pairs to make more
matches.
The most frequent reason for ABO incompatibility, preventing living donors from donating is
a blood group A or B donor and a blood group O recipient. There are many vice-versa pairs
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but the problem is that the blood group O donors are universal donors for all blood groups.
They can give the kidney directly to their recipients than rather to a stranger. When the cross-
match is positive with own one's recipient, but this recipient has a negative cross-match with
blood group A or B donor from another couple, the problem is solved by exchanging the
kidneys between these pairs. Another reason for kidney exchange is when the O to A or B pair
get a better HLA matching from 6 miss-matches to 0-3 miss-matches by swapping the kidney
with a A or B to O pair.
The pairs involved in a paired exchange program are interviewed to exclude any coercion of
the donor, they are informed about the advantage and the risk of the living donation and the
informed consent is obtained. Beside that, all donors undergo psychological evaluation.
The inclusion criteria pursued the goal of exchanging equivalent kidneys with equivalent size,
anatomy, similar renal function and similar age. The donor are assessed preoperatively by
high resolution iv pyelograms, quantitative renal scan and spiral CT scan or MRI. As a general
rule, the donors accept to join this program as this is the only way to help their relatives or
friends. The transplants involving two or three pairs can be performed simultaneously
excepting the session with more than three pairs when the transplants are performed succes‐
sively. All the transplants are performed by the same surgical team in respect to the principle
to equivalent quality of the surgical act.
The basic principle of kidney exchange is the equivalent exchange. To accomplished this, high
resolution preoperative work-ups required and unpredicted situation which can hinder
harvesting are avoided. This way, simultaneously harvesting is not mandatory.
By using kidney exchange, the recipient benefit from the better matching as well as the known
advantages of living donation. Paired kidney exchange reduce the duration of dialysis before
transplantation and expand the pool of living donors.
In the countries where the living donation is the main source of organs, cross-over transplan‐
tation may become more popular as it increase the number of transplants. The kidney exchange
program has to be promoted as it offers solutions where apparently there is none.
Transplantation of ABO incompatible pairs. Developed initially in countries with predominant
living donation, transplantation of a ABO incompatible kidney is a demanding task but it was
possible mainly due to development of more potent immunosuppressive drugs which reduces
the risk of hyperacute rejection [67]. In japan, transplantation of a ABO incompatible kidney
from a living donor is preferred to a deceased donor graft but the experience already acquired
was extended in many other countries for recipients having only a ABO incompatible donor
willing to donate [68].
The procedure involves a pretransplant treatment in order to remove the ABO antibody and
to prevent furture production. Thus, Rrituximab is administred one month before transplan‐
tation followed by plasmapheresis 7 to 14 days before transplantation. With Rituximab there
is no need for splenectomy and plasmapheresis is done in alternate days or even daily in order
to reduce the ABO antibody titer under 8. The plasma removed is replaced with albumin
solution and a combination of albumin and fresh frozen solution just immediately before
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transplantation to correct the coagulation. A key point is the administration of IVIG immedi‐
ately after each plasmapheresis. The plasmapheresis is continued in the first two weeks after
transplantation if ABO antibody titer was over 256 before Rituximab, if there is an increase of
ABO antibody more than three times after transplantation, and if the serum creatinine
increases more than 15% in two weeks after transplantation. The immunosuppression includes
Tacrolimus, mycophenolate mofetil and steroids. In the first three weeks, the patient is at high
risk of developing hyperacute humoral rejection, thus a graft biopsy is warranted whenever
the serum creatinine increase over 15% in two weeks [69].
The use of specific immunoadsorbtion instead of plasmapheresis is not only less aggressive
but also more effective since it allows more than two plasma exchange equivalent per one
session [70].
Even if renal transplantation agains ABO blood group is expensive and, due to the increased
immunosuppression, increases the infectious and malignancy risk, graft function at five years
is slightly similar to transplantation of ABO compatible grafts [68].
2.9. Commercial renal transplantation
World Health Organization condemned the sales of organs since 1989. Sales of organs and
tissues has been made illegal in the majority civilized states of the world. The difference
between altruistic donation of a kidney and selling off a kidney is viewed as similar to the
difference between marriage and prostitution. The first is a sacrament, the second a sin.
Reimbursement for expenses related to the donation process, such as for traveling and lodging
is not prohibited, although a formal mechanism to make such reimbursements is not available
everywhere, a factor that could act as a decentive to donation for some potential donors.
Iran is currently the only country in which payed donation is officially sanctioned, almost all
the donors are pour and uneducated and follow-up studies have shown that their lives are not
improved.
Despite the legal constraints on organ sales, commercial kidney transplantation is a common
phenomena in many parts of the world, and in some cases has been linked to criminal activity.
The donors are typical pour or under great financial stress, the recipients are often wealthy or
come from other wealthier countries, and middleman or brokers are often involved.
Arguments against payed donation shows:
• The donor's choice is not voluntary because he is compelled by circumstances of poverty to
donate a kidney. Poverty-stricken donors choose what they see as the best of a group of bed
options. Compared to some other possibilities such working under unsafe conditions,
kidney donation might carry less risk to the donor than other choices and at the same time
might accomplish more good for society and for the donor.
• Paid donors are usually pour and uneducated, so making them understand the risks is all
but impossible.
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• Commercial donation will result in the rich having access to organs for transplantation while
the pour do not.
• Donors will be exploited by unscrupulous middleman and sometimes, even by the sur‐
geons. The medical care of both donor and recipient will suffer generally.
• The pour don't know how to handle the money that comes to them and will make no
permanent difference in their poverty. This perception may be based on experience with
lottery winners and other recipients of a sudden winfall. Donors will have widely differing
abilities to plan for the future and would be difficult to predict what they will do with the
payment for their donation. The possibility off misuse of money does not justify the
overriding the donors wish to give up a kidney.
• During its entire history, transplantation has relayed on the altruism of donors and their
families. Commercial donation would change the fundamental character of organ donation
and likely would lead to the disappearance of altruistic donor. If any transplants are payed
for, all will have to be. Most of payed donors are giving an organ to a specific individual.
Payed donors would not have a choice about recipient. Thus, altruistic donation should
continue.
• The initial enthusiastic support of organ transplantation has been replaced by suspicion.
Although no evidence has proved the charges that are widely accepted urban myths
regarding transplantation. This includes stories of people, particularly south-american
children being kidnapped and killed for their organs, and people being drugged and
kidnaped only to awaken in an alley with a flank incision and no kidney on that side. The
myths can only be dispelled by the education, nothing else. Moreover, the possibility exists
that skillful paper editors and television producers will exploit current practices for
purposes of sensationalism.
Available data on the outcome of organ vending for the donors, indicates that the most of them
have a pour outcome. On the other side, recipient of vended organ are subject to an increased
risk for complications, particularly infections, likely as a result of a break-down of trust and
honesty that is a byproduct of commercialization of organ donation. Evidence from several
countries has shown that commercialization of organ donation comes at the expense of
program for the related and unpaid living unrelated donation.
3. Cadaveric donation
The modest increase in cadaveric renal transplant in USA has been achieved in principally by
extending use of older and younger donors [71]. Fortunately, the death from motor vehicle
accidents has decreased over the passed 20 years mainly due to laws meant to increase the
safety on the road: the seat belt laws, passive restraints, child safety seats, and stricter drunk
driving laws. The greatest number of lives saved by improved highway safety has been
specially at the 15 to 40 years old age group. On the other hand, another concern is related to
the estimation that 10% of potential donors might be ineligible because of HIV infection [72].
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In the same time, the number of older cadaver donors doubled between 1990 and 2000
especially due to a 10 fold increase in donors older than 60 years.
The percentage of donors dying in motor vehicle accidents decreased from 34.4% to 24.00%
while the percentage of donors dying from stroke increased from 27% to 42% [71]. Despite the
decrease in motor vehicle accidents, enough deaths still occur under circumstances that allow
transplantation and could reduce the gap between the need for and the supply of kidneys in
all civilized states in the world. The failure to make use of these organs has been attributed to
the failure of the intensive care unit staff to recognize potential donors as well as the high
refusal rate by families of potential cadaveric donors. Multiple new mechanisms for preventing
potential donor from being missed in ICU appear to have been successful. Hospital staff are
recognizing over two thirds of potential donors, are asking their families about donation but
only half of them agree to donate.
Much attention has been focused on disparity among different ethnic groups as organ donors.
A study of 1772 requested donation in come important cities from USA reported a family
refusal rate of 17% in whites, 43% in Hispanics, and 45% in blacks [73], but the situation has
changed in last period due to intensive efforts done to encourage minority families to donate.
As a consequence the rate of cadaver kidney donation became similar for whites, blacks and
Hispanics but remained low for Asians. Estimate of the overall refusal rate in the USA is
between 38% to 50%. The refusal to donate lead to a 4755 kidneys lost for donation but the true
potential in higher since we can't determine the real number of potential donors. This number
would have enclosed 81% of the gap between the yearly increase in need and the available
kidneys. Even so, the shortage of kidneys can not be closed by eligible donors lost by families
refusal to donate and the difference would have to be provided by new cadaveric sources and
by living donation.
3.1. Disparity among attitudes regarding cadaver donation
Even it might be only a believing, there is a dichotomy between the public and the medical
community regarding cadaveric organ donation. The medical community is preferring
cadaver organ donation since there are less concerns on the quality and risks associated with
the donor's organs. Physicians don't share the cultural and religious believes of families
opposed to organ donation. The doctors are relieved of concerns regarding doing harm to the
donor because they often see the main problem as one that may be corrected by education and
right information.
Even though over 90% of the public supports allowing living donation [74], many people do
have reservations about cadaveric organ donation due to cultural and religious beliefs or
beliefs that the dead can still suffer. The concept of brain death remains only a concept when
it is about a loved one who has died unexpectedly. Families also express concern that the
deceased’s own wishes cannot be known or carried out. People might fear that being identified
ahead of time as an organ donor would lead the medical team to make less than the maximal
effort to save them [75].
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3.2. Legislation means
An array of various laws have been passed to maximize the number of cadaveric donor
transplants. In USA, the Uniform Anatomical Gift Act, have been passed for over 30 years by
american Congress and authorize individuals to give their organs and specified who could
give consent if the donor were unable to do so [76]. By now, many states have such a law in
place and many of them use the driver license as a donor card.
"Routine inquiry" is active in many hospitals in Europe and USA. Majority of the hospitals
who are doing or not transplantation, have routine inquiry policies which qualifies for social
reimbursement. Hospitals are required to notify families of potential donors about the
possibility of donation and to notify organ procurement agency approved by health care
finance administration. In the first years after the passage of required request laws, donation
increased slightly but then reached a new plateau.
Another way to approach organ donation, especially in European countries is that of presumed
consent. Unless the potential donor has previously expressed a wish not to donate, he is
presumed to have agreed to donate. The role of the family is to confirm that the deceased has
not expressed an unwillingness to be a donor. The application of the law is variable and
approximatively one half of the nations continues to depend on family consent in practice. The
effect of donation have been variable; the refusal rate in Austria and Belgium, where the law
is strictly applied dropped under 10%. In USA, public opinion shows little support for
presumed consent law with only 7% supporting this approach.
An alternative to presumed consent has been proposed in the USA which is mandated choice
[77]. When getting or renewing a driving license, a person would have to decide whether to
become a potential donor, and the person's choice would take precedence over the family's
wishes.
Another law which is active in some states in USA and some countries in Europe, is to provide
a compensation for the donor's family. The fund for such thing is obtained by voluntary
donations. One thing which is important here that the law makes the distinction between
purchasing organs and bestowing a gift to the family in appreciation of its generosity.
3.3. Expanding donation criteria
When efforts that increase the consent rate for cadaver donors, another approach expanding
the criteria for an acceptable cadaver donors, also has attempted to increase the number of
kidneys available for transplantation. Less than 25% of the increase in cadaveric donors has
come from traditional pool age 16 to 50 year age donors. The criteria have been expanded
further in some instances by use of donors with encephalitis and core antibody positivity for
hepatitis B [78]. Recent data have confirmed that safety of even using kidney from infected
donors with blood cultures with pseudomonas and candida, provide appropriate antibiotic
treatment is given [79]. There are studies which determined that bacteriemia accounted for
30% of medically unsuitable kidneys in brain death potential donor. There are also transplan‐
tation of horse shoe kidney [80] or kidneys from non renal organ transplant recipient which
have to be mentioned. From any point you are going to look at this problem, the greatest
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potential to increase the potential donor pool comprises non-hard beating cadaver kidneys
and kidneys from older donor.
Situations requiring edge biopsy
All people with normal renal function regardless of age (graft biopsy in donors over 60 years)
Diabetic donors with normal renal function and without severe proteinuria
All hypertensive donors with normal renal function
All hypotensive donors
Infected donors excluding viral hepatitis, HIV, Jakob-Creutzfeldt disease, viral encephalitis, malaria, disseminated TB
CMV + RPR
Positive urine cultures without pyelonephritis
Bacteremic donors
Donors with abnormal renal function
Donors at high risk for infection (but negative on high sensitive tests)
Donors with a history of malignancy disease-free for two years
Skin tumors without metastases, excluding melanoma
Primary CNS tumors without VP shunt
Adapted from [65]
Table 5. Expanded criteria for cadaveric donors
Non heart beating donors where widely used before the definition of brain death was accepted.
They remain the major source of cadaver donors in countries such as Japan and Mexico, where
brain death was recognized officially only recently and where social acceptance it is still limited
[82]. Non heart beating donors yield about 5% of all cadaveric kidneys transplanted in USA.
Use of non-heart beating cadaver donor kidneys has increased in last years. The one year
survival of graft from non-heart beating donors was 83% and for brain death donors was 86%.
Early function was not as good: 48% of recipient of non-heart beating donor kidneys required
dialysis in the first week after transplantation compared to 22% of the recipients of kidneys
from brain death donors. Primary non-function was slightly increased also (4% versus 1%).
The serum creatinine level at discharge from hospital was higher in the first group. At one year
follow-up, the serum creatinine levels for the two groups was, in fact, similar (1.9 mg/dL versus
1.8 mg/dL). When traumatic death were analyzed separately, the one year survival of non heart
beating donors kidneys was 89% compared with 70% one year survival for non-traumatic
death. Not all programs have found the same results from non-heart beating donors, but the
finding of more frequent delayed function and need for dialysis has been universal. The
potential for increasing the donor supply from non-heart beating donors has been estimated
to be as high as 40% [83].
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3.3.1. Older donors
Already, older donors are a major source of cadaveric donation. Some doctors found out an
inferior outcome from transplants from cadaveric donors over 55 years of age. Not only did a
higher percentage of recipients of such kidneys required dialysis but one year serum creatinine
level was higher than that from recipient of transplants from cadaveric donors aged 5 to 55
years and the estimated halve life of the kidney was 5.8 +/- 0.3 years compared to 11+/- 0.3
years. Other analysis have found similar results but suggests that the adverse effects of the
donor ages affect only certain subgroups particularly black recipients.
3.3.2. Hypertension
Recipients of kidneys from donors with hypertension were more likely to have anuria and to
require dialysis immediately after transplantation. Their serum creatinine level was significant
higher at one year than that of recipients of kidneys from donors who were not hypertensive
and the predictive graft survival was shorter (halve life of 7.7 +/- 0.5 years versus 10.7 +/- 0.3
years). Graft survival was better with 1 to 5 years of hypertension compared to 6 or more years
of hypertension. The difference in serum creatinine and predicted graft survival between
kidneys from diabetic and non-diabetic donors was of borderline statistical significance. Serum
creatinine at one year was 1.8 +/- 0.8 mg/dL in recipient of kidneys from diabetic donors
compared with 1.6 +/- 0.8 mg/dL in recipients of kidney from non-diabetic donors. Predicted
halve life in this graft was 8.4 +/- 1.5 years compared with 10.1 +/- 0.3 years.
3.4. Strategies for increasing organ donation
In developing new strategies for increasing kidney available for transplantation we would do
well to remember that from its beginning organ transplantation has relied on public good will
and support. When public opposition exists, we sometimes avoid using approaches that we
find ethically acceptable. Because we really don't know what ideas or practices will strengthen
public support for all organ donation the introduction of new practices should be undertaken
as pilot projects.
The public already accept living donors who were not considered 50 years ago such unrelated
living donors and spouses, which are now widely excepted. Once we accept the donors
autonomy and remind ourselves that the risk to the donor is not related to his relationship to
the recipient, we will be able to accept the wide arrange and greater number of emotionally
related donors. We need to understand that the altruistic donor, although unusual, is not
pathologic. The altruistic donor can be considered an emotionally related donor who is
emotionally related to all mankind. Thus, this approach to this type of donor is not to keep a
registry of willing donors and their HLA types. The altruistic donor is not waiting for the right
HLA type but for the right story. The acceptance of donor autonomy would allow for accepting
donors with increased risk, but will require careful follow-up thus an increased risk of
complications can be recognized.
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3.5. Conclusions
During the last period of time, there was a spite of papers from individual countries and
registries, which examined the ways in which the number of kidney donors could be increased.
Most studies examined single initiatives, such as changing the transplant law, rather than the
development of integrated donor programs. The act of donation is a complex phenomenon
depending on many factors and interactions, few of which individually have been proven
useful or generally applicable throw the out the european community. Well designed studies
are needed urgently. A donation is the result of a chain of events, the final result of which will
depend upon its weakest link.
Even when the individual links have been strengthened, each element of the process of
donation must be integrated into the operational policies developed in toon with national
moral and cultural values. It is easy to set a minimum standard to which countries should
aspire. But it is another matter to recommend specific, donor promoting activities for which
individual countries and profesional organizational should aim.
Although, living donor rate are no increasing in Europe, rates could be further improved at
different stages in the referral process:
• Nephrologist at non transplanting as well as transplanting centers, should be encouraged
to discuss openly the subject of living donation with family of patients suffering ESRD,
preferably before the patient begins dialysis. This will results in predialysis transplantation,
increased transplant rates, and is more efficient in case of reduced dialysis resources.
• Canceling facilities (e.g. by a senior nurse or living donor coordinators) should be available
to discuss screening tests, provide information, and arrange eventually reimbursement of
donor expenses allowed in law.
• Each transplant center should work to an approved screening protocol, such that the
predicted mortality risk of living donation does not exceed 1 in 3000 cases.
• If legally permitted, living unrelated donors should be encouraged. In many countries in
Europe, altruistic non related kidney donation is allowed legally, provided that checks are
made for altruistic motivation and exclusion as far as possible of the possibility of organ
sale.
• Non-directed living donor transplantation between altruistic donor and recipient unknown
to the donor is possible and have been developed in few centers. Although controversial,
there seem no moral or social reason to exclude such donors. However, there are ethical and
legal concerns about this type of donation, which at the moment make it difficult to include
in a recommendation list.
Increase supply and use of cadaveric kidneys:
Donor cards. In many countries publicity schemes encourage the population to carry donor
cards, or to register their wish to donate (opting-in) on a computerized donor register. Even if
in UK 8 mil. of individuals are now registered in the opting-in computer, only 10% of the
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population is currently caring donor cards. No more than 50 donor per year results from this
initiative. For the success of such schemes, continuous publicity is essential to increase opted-
in donors and transplant centers. Intensive care physicians and transplant coordinators should
be mandated to access registry routinely, to identify the wishes of potential cadaveric donors.
Improved organization and resources. Services must be more organized and better resourced
to increase cadaver donation. In several countries, the number of intensive care beds is
probably too low to achieve more than 20 donors per million from intensive care patients. In
high donating countries, with better resourced intensive care units, the staff responsible for
donation (transplant coordinators), have been expanded and given proper financial support.
Transplant coordinators are also to be given the responsibility of public relations, with the aim
of avoiding adverse media publicity, and liaising with the coroners.
Opting-out legislation. The introduction of opting-out legislation appears on first site of the
data available to be associated with the increased rates of cadaveric donation. In Europe, four
countries which exceeded 20 kidneys donor per million population per annum, all have opting-
out legislation. In France however, opting-out legislation has not achieved such a successful
donation rates. This may be because France choose initially, hard line opting-out, in which
donation takes place if the donor has not opted-out irrespective of families wishes. Adverse
publicity led to a softening of the practice, which consequently increases the donation rates.
Other countries which presumed consent law practices soft presumed consent, in which the
families are taking into account in all situations. In general, countries with informed consent
do not perform as well, main exception being USA, where kidney donation rates exceed 25
donors per million population.
Criteria for donor suitability. Non-heart beating donors (NHBD) are well known to produce
a high rate of primary non-function and their acceptability was low. Recently introduced in
situ perfusion of the dead bodies, which has been successfully developed in UK and Holland,
are bringing in encouraging results. After harvesting, kidneys may be put into continuous
perfusion machine, and their viability assessed using flow measurements and urinary and
enzyme excretion. As a matter of fact, presumed consent legislation will allow more NHBD.
Rapid intraarterial cold perfusion over recently deceased persons should be allowed before
family consent low operate but perfusion without relatives permission is technically unwar‐
ranted assault. Agreement by a coroner should allow perfusion without permission and that
could expand significantly NHBD.
Elderly donors. Even if long term survival for kidneys from elderly donors (over 60 years old)
is 10-15% less than those taken from younger donors, better results may be obtained with
carefully selected older donors and shortening of the cold ischemic time.
A good quality organ must be guaranteed to the recipient and every transplant center must
established its own guidelines on organ acceptability. If the transplant center uses a less than
optimum organs from old subjects to expand the pool of donors, the donors must be evaluated
according to age, vascular condition and renal function. The inferior limit for a single kidney
transplant is considered creatinine clearance more than 60 mL/min. If the calculated creatinine
clearance is between 60 and 50 mL/min. the donor may be considered marginal. If the calcu‐
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lated creatinine clearance is less than 50 mL/min. than the kidney should not be used for a
single transplantation, however, as they are organs that nobody wants they can be used for
dual transplantation. When this policy is established, it is necessary to inform the patient on
the waiting list.
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